Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PRESTIGE CONSUMER HEALTHCARE INC.

(PBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Prestige Consumer Healthcare : Sidoti Fall Small Cap Investor Conference

09/23/2021 | 03:02am EST

S e p t e m b e r 2 2 n d , 2 0 2 1

Sidoti Fall Small Cap Investor Conference

Safe Harbor Disclosure

This presentation contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the Company's expected financial performance, including revenues, adjusted EPS, free cash flow, and organic revenue growth, and the related impact of the TheraTears acquistion; the Company's ability to perform well in the currently evolving environment and execute on its brand-building strategy; the expected market share and consumption trends for the Company's brands, and the recovery of COVID-impacted categories; the Company's ability to easily integrate and create value from its acquisition of TheraTears; and the Company's ability to execute on its disciplined capital allocation strategy. Words such as "trend," "continue," "will,"

"expect," "project," "may," "should," "could," "would," and similar expressions identify forward-looking statements. Such forward-looking statements represent the Company's expectations and beliefs and involve a number of known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors include, among others, the impact of the COVID-19 pandemic, including on economic and business conditions, government actions, consumer trends, retail management initiatives, and disruptions to the distribution and supply chain; competitive pressures; the impact of the Company's advertising and marketing and new product development initiatives; customer inventory management initiatives; fluctuating foreign exchange rates; difficulty integrating TheraTears and other risks set forth in Part I, Item 1A. Risk Factors in the Company's Annual Report on Form 10-K for the year ended March 31, 2021. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date this presentation. Except to the extent required by applicable law, the Company undertakes no obligation to update any forward-looking statement contained in this presentation, whether as a result of new information, future events, or otherwise.

All adjusted GAAP numbers presented are footnoted and reconciled to their closest GAAP measurement in the attached reconciliation schedule or in our August 5, 2021 earnings release in the "About Non-GAAP Financial Measures" section.

S i d o t i F a l l S m a l l C a p I n v e s t o r C o n f e r e n c e

Contents

  1. Introduction to Prestige Consumer Healthcare

II. Brand Building Playbook

  1. Financial Profile & Capital Allocation
    IV. The Road Ahead

S i d o t i F a l l S m a l l C a p I n v e s t o r C o n f e r e n c e

Introduction to Prestige Consumer Healthcare

Who We Are: Helping Consumers Care for Themselves

eye drops per year

throat drops for every cold season

doses of pain relief per week

infections treated annually

Source: Company records

S i d o t i F a l l S m a l l C a p I n v e s t o r C o n f e r e n c e

5

Disclaimer

Prestige Consumer Healthcare Inc. published this content on 21 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 September 2021 07:01:02 UTC.


ę Publicnow 2021
All news about PRESTIGE CONSUMER HEALTHCARE INC.
11/15INSIDER SELL : Prestige Consumer Healthcare
MT
11/15DA Davidson Adjusts Price Target on Prestige Consumer Healthcare to $63 from $61, Keeps..
MT
11/04Q2 2022 Prestige Consumer Healthcare Inc. Earnings Conference Call
PU
11/04Prestige Consumer Healthcare Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2022 Gui..
MT
11/04PRESTIGE BRANDS : Fiscal Q2 Earnings Snapshot
AQ
11/04PRESTIGE CONSUMER HEALTHCARE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO..
AQ
11/04Prestige Consumer Healthcare Inc. Reports Earnings Results for the Second Quarter and S..
CI
11/04Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results - Form 8-K
PU
11/04PRESTIGE CONSUMER HEALTHCARE INC. : Results of Operations and Financial Condition, Regulat..
AQ
11/04Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Posts Q2 EPS $1.02
MT
More news
Analyst Recommendations on PRESTIGE CONSUMER HEALTHCARE INC.
More recommendations
Financials (USD)
Sales 2022 1 060 M - -
Net income 2022 197 M - -
Net Debt 2022 - - -
P/E ratio 2022 14,5x
Yield 2022 -
Capitalization 2 826 M 2 826 M -
Capi. / Sales 2022 2,67x
Capi. / Sales 2023 2,58x
Nbr of Employees 505
Free-Float 91,6%
Chart PRESTIGE CONSUMER HEALTHCARE INC.
Duration : Period :
Prestige Consumer Healthcare Inc. Technical Analysis Chart | PBH | US74112D1019 | MarketScreener
Technical analysis trends PRESTIGE CONSUMER HEALTHCARE INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 56,41 $
Average target price 68,00 $
Spread / Average Target 20,5%
EPS Revisions
Managers and Directors
Ronald M. Lombardi Chairman, President & Chief Executive Officer
Christine Sacco Chief Financial Officer
Jeff Zerillo Senior Vice President-Operations
John E. Byom Independent Director
Sheila A. Hopkins Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PRESTIGE CONSUMER HEALTHCARE INC.61.77%2 826
JOHNSON & JOHNSON1.82%419 109
ROCHE HOLDING AG16.05%336 162
PFIZER, INC.46.70%303 095
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049